Let’s not forget, patients have been treated with DCVax-L in the UK since 2014 with the specials program, I’m sure all that patient data is part of the application process. Furthermore, that data may also provide the proverbial “Ace up my sleeve”, what better RWE than 100’s of real world patients receiving DCVax-L over the past 9 years.
Market Data 
Markets 
AI
